- Exchange: NASDAQ GM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
MediciNova Inc+ Add to Watchlist
MNOV:US2.1400 USD 0.1365 6.00%
As of 20:10:00 ET on 12/19/2013.
Company Profile for MediciNova Inc (MNOV)
MediciNova, Inc. acquires, develops, and commercializes small molecule therapeutics. The Company, through alliances with Japanese pharmaceutical companies, has built a portfolio of drug candidates. MediciNova researches treatments for asthma, status asthmaticus, insomnia, interstitial cystitis, cancer, multiple sclerosis, preterm labor, urinary incontinence, and anxiety.
Key Executives for MediciNova Inc (MNOV)
|Yuichi IwakiPresident/CEO/Interim CFO/Founder||Kazuko MatsudaChief Medical Officer|
|Masatsune OkajimaVP/Head:Japanese Office||Geoffrey G O'BrienVice President|